NCT07364565 The Antiplaque and Antigingivitis Effect of Pure Green Tea Mouth Wash Compared to Placebo and Essential Oils Mouth Washes
| NCT ID | NCT07364565 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King Abdullah University Hospital |
| Condition | Dental Plaque |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2025-12-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to to evaluate the antiplaque and antigingivitis effect of pure green tea mouthwash compared to placebo and essential oils mouthwashes in healthy patients. The main questions it aims to answer are: * Does pure green tea mouthwash effectively reduce dental plaque? * Does pure green tea mouthwash reduce gingival inflammation? Researchers will compare pure green tea mouthwash to Listerine Total Care, Listerine Green Tea, and placebo to see if there is a difference in plaque accumulation and gum inflammation reduction. Participants will be prohibited from using any sort of oral hygiene parctice for the whole study period (3 weeks). Instead, they will rinse with 10 ml of their assigned mouthwash twice daily for 30 seconds. Plaque index, gingival index, and staining index will be examined at multiple intervals and participants will rate their sense of oral freshness and good breath.
Eligibility Criteria
Inclusion criteria: * Non-smokers * Systemically healthy * At least 24 teeth in the functional dentition, excluding third molars * Clinical diagnosis of periodontal health (no periodontal pockets \> 3 mm, bleeding on probing percentage \< 10%, and no attachment loss). Exclusion criteria: * Smokers. * Medically compromised patients. * Pregnant woman. * Allergies to green tea or EO. * Any condition that might affect the periodontal tissues. * Patients with any carious lesions (initial or active). * Patients who have overhang restorations, poorly designed crowns or bridges, and ortho retainers. * Use of systemic antibiotics or anti-inflammatory medications within 3 months prior to enrolment.
Contact & Investigator
Lana Bader, DClinDent Perio
STUDY DIRECTOR
Jordan University of Science and Technology
Frequently Asked Questions
Who can join the NCT07364565 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dental Plaque. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07364565 currently recruiting?
Yes, NCT07364565 is actively recruiting participants. Contact the research team at lmbader4@just.edu.jo for enrollment information.
Where is the NCT07364565 trial being conducted?
This trial is being conducted at Irbid, Jordan.
Who is sponsoring the NCT07364565 clinical trial?
NCT07364565 is sponsored by King Abdullah University Hospital. The principal investigator is Lana Bader, DClinDent Perio at Jordan University of Science and Technology. The trial plans to enroll 44 participants.